Acta Scientific Medical Sciences

Conceptual Paper Volume 2 Issue 6

Inflammasome and its Component NLRP3 Plays a Major Role in Tumorigenesis

Anuradha Ratna*

Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA

*Corresponding Author: Anuradha Ratna, Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA.

Received: July 30, 2018; Published: August 10, 2018

Citation: Anuradha Ratna. “Inflammasome and its Component NLRP3 Plays a Major Role in Tumorigenesis”. Acta Scientific Medical Sciences 2.6 (2018).

  Chronic inflammation plays a crucial role at different stages of tumor development, including initiation, invasion and metastasis [1-4]. Many cancers are associated with chronic inflammation, for instance, hepatocarcinoma from Hepatitis B or C virus infection, gastric cancer due to Helicobacter pylori and colorectal cancer from ulcerative colitis [5,6]. Altered cell signaling pathways involving kinases and their downstream transcription factors have been established as the major contributors associated with inflammationinduced carcinogenesis [7]. Inflammation, particularly involving inflammasomes, modulates carcinogenesis through secretion of various inflammatory cytokines. Inflammasome is an important multimolecular complex formed by NOD-like receptor (NLR) family members that regulates inflammatory immune responses by activating proteolytic enzyme caspase-1 [8]. Activation of inflammasome via canonical pathway promotes caspase-1 dependent maturation of proinflammatory cytokines IL-1β and IL-18 as well as induces pyroptotic cell death in response to pathogen-associated molecular patterns or endogenous danger signals [9]. Proinflammatory cytokines attracts a myriad of immune cells such as neutrophils, macrophages, monocytes and leukocytes to organize a local immune network within tumor microenvironment. In inflammatory cells, caspase-1 activation can initiate pathways leading to sterile inflammation, production of trophic factors required for cancer cells and their stroma [10].

Copyright: © 2018 Anuradha Ratna. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.



Member In




News and Events


  • Special Issue on Reviews
    Acta Scientific Journals has been started Special Issue on Reviews, researchers from world wide welcoming for submission of their reviews on any topic by on/ before August 30, 2019. Special Issue is going to be released on September 10, 2019
  • Submission Timeline
    Last date for submission of articles is August 30, 2019.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Papers of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of “Best Article of the Issue”.
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.
  • Contact US